Try our Advanced Search for more refined results
Life Sciences - August, 2024
289 articles
- McKesson, Others To Pay Benefit Plans $300M In Opioid Deal
- Calif. Legislature OKs Ban On 6 Food Dyes In Public Schools
- Doctor In Matthew Perry's Death Makes 1st Court Appearance
- Wheeling & Appealing: The Latest Must-Know Appellate Action
- Align Tech Cuts $27.5M Antitrust Deal With 1.45M Consumers
- Nebraska Expected To Vote On Medical Marijuana Legalization
- Period Tracker App Users Seek Class Cert. In Data-Selling Suit
- Bayer Antitrust Case Hinged On Evolving Market Definition
- Philips Accuses SoClean Of Discovery Delay In CPAP Recall
- IP Hot Topic: The Intersection Of Trademark And Antitrust Law
- Being An Opera Singer Made Me A Better Lawyer
- Cancer Detection Co. Valued At $375M In SPAC Merger
- Fall IPO Pickup Could Be A Prelude For 2025 Recovery
- Pa. Justices To Examine Axing Of 'Red Book' Drug Pricing
- Jury Clears Ore. Hospital That Implanted FDA-Flagged Mesh
- Lannett Says Areva Reneged On Cancer-Drug Deal After Ch. 11
- Comer Tells PBMs To Correct Record On Role In Drug Pricing
- Seattle Biotech Can't Immediately Force Out LA Times Owner
- Pacira To Appeal Generic's Win In Pain Drug Patent Fight
- Nektar Can't Get Docs It Says Show Lilly As 'Thieves, Liars'
- Convicted Drexel Prof Says Records Would've Swayed Jury
- What Drug Cos. Must Know About NY Price Transparency Law
- Jazz Hits Teva With Patent Suit Over Narcolepsy Drug
- How Law Firms Can Avoid 'Collaboration Drag'
- Merck Must Face Class Claims In Vaccine Antitrust Suit
- CyDex Says Bexson Breached Deal By Misusing Pharma IP
- J&J Spinoff Beats Suit Over Tylenol 'Rapid Release' Labels
- Lipitor Buyers Seek Final OK For $35M Deal In Antitrust Fight
- Walgreens Brass Hid Pharmacy Division Woes, Suit Says
- Jazz, Hikma Must Face Bulk Of Xyrem Antitrust Suit
- Calif. Couples Drop FujiFilm Suit Over Destroyed Embryos
- Del. Justices OK Mid-Case Appeal In Zantac Class Suit
- High Court Told Tyvaso Row Petition Based On 'False' Premise
- What BIPA Reform Law Means For Biometrics Litigation
- Regeneron Sues Sandoz Over Dozens Of Eye Drug Patents
- Litigation Funding Disclosure Key To Open, Impartial Process
- Biotech Biz Hid Risks Of Gene-Editing Trial, Investor Claims
- Cherokee Nation's Opioid Suit Sent Back To State Court
- USPTO Sued For Rejecting Blood Pressure Drug Patent
- NY Pension Funds Join Illumina Deal Suit Pile-On In Del.
- Fed. Circ. Won't Speed Up Apple Watch Ban Appeal
- Connecticut Litigation To Watch In The 2nd Half Of 2024
- The Licensure Landscape For Psychedelics Manufacturers
- Sheppard Mullin Adds Another McDermott Healthcare Pro
- Vt. High Court Affirms Denial Of Benefits To Marijuana Patient
- What NFL Draft Picks Have In Common With Lateral Law Hires
- Freshfields Steers UCB's $680M Sale Of Chinese Portfolio
- Rival Can't Avoid Drugmaker's False Ad Claim Over Pain Med
- Biotech Investor Sues In Chancery Over Alleged IP Diversions
- Hikma Urges Full Fed. Circ. To End Vascepa Skinny-Label Suit
- Ex-Ingersoll Rand Exec Could Be Stuck With Noncompete
- Masimo, Apple Fight Over Jury Hearing Trade Secrets Claims
- Shareholder Attys Get $11M For Taro Price-Fixing Deal
- FTC Mulls Proposal To Alter Puerto Rican Pharmacy Deal
- Replacing The Stigma Of Menopause With Law Firm Support
- McKesson Inks $2.49B Deal For Cancer-Focused Biz
- NY Can't Sue Groups Over Abortion 'Reversal' Ads, For Now
- Abbott Judge Suggests $54M Judgment In Test Strip TM Case
- Biotech Co. In Wrongful Death Suit Over Destroyed Embryo
- Matthew Perry Death Suit Could Blow Past Calif. Damage Cap
- McKinsey Opioid Suits Sent Back To NY, Illinois State Courts
- 9th Circ. Reverses 'Patent Misuse' Ruling Against CR Bard
- Ex-Exec Can't Reverse Medtronic Insider Trading Conviction
- The Biggest Product Liability Cases Of 2024: A Midyear Report
- Drugmakers' 'Subjective Beliefs' Obscured In Antitrust Case
- Albertsons-Kroger Deal Tests FTC's Stepped-Up Merger Policy
- Class Actions At The Circuit Courts: August Lessons
- Leveraging Policy Changes To Achieve AI Patent Eligibility
- Covington-Led Getinge Pays $477M For Organ Transplant Biz
- Planning Law Firm Content Calendars: What, When, Where
- Delaware Lets Ventis Move Pacira's False Ad Suit To Calif.
- Firms Seek $20M Fee After $58M Deal In Shire Antitrust Suit
- PBMs Can't Yet Duck Municipalities' Claims In Opioid MDL
- Texas Appeals Knocks $1M Hernia Mesh Fee Ask Down To $135K
- 2 Biotech Firms File Plans To Go Public As IPO Pipeline Grows
- Mich. Panel Upholds Block Of 24-Hour Abortion Waiting Period
- Zantac Cases Must Remain In State Court, Conn. Judge Rules
- Texas Tells High Court It's Not Idaho '2.0' In HHS Abortion Row
- Ex-MiMedx Sales Rep Says Fraud Schemes Pushed Her Out
- USPTO Tells High Court To Skip Double-Patenting Fight
- Ga. Mineral Co., Insurer Strike Deal In Talc Coverage Suit
- Deals Rumor Mill: Saudi Fund, Disney-Reliance, Repligen
- Playing Golf Makes Me A Better Lawyer
- Fed. Circ. Won't Rethink IP Safe Harbor Case
- Spine Implant Caused Patient's TB, Suit Says
- Cannabinoid Co. Sacked Exec For Flagging Fraud, Suit Says
- Hedge Fund Priest Sues SEC Over Proposed Industry Ban
- 9th Circ. Doubts Idaho Trans Health Ban Doesn't Discriminate
- Judge Rules Lack Of Expert Dooms Families' Tylenol MDL
- Law Firms Should Move From Reactive To Proactive Marketing
- Calif. AG Secures Rite Aid Deal Ensuring Pharmacy Access
- Mesh Was Implanted After Serious FDA Alert, Jury Hears
- Ala. AG Can't Prosecute Aiding Abortion Travel, DOJ Says
- SF Police Can't Sue Navy Over Toxic Shipyard, 9th Circ. Says
- Advanced Bionics Sues Med-El At ITC Over Implant Patents
- Lender's $13M Atty Fee Reserve Bid In Eiger Ch. 11 Plan Nixed
- Fed Circ. Finds No Fault In Denial Of Flu Vaccine Claim
- Insider Trading Won't Impact Pilot's Tax Sentencing Guidelines
- Vax Patent Battles Heat Up As Attention On Pandemic Wanes
- Ex-Client Opposes Amicus In McCarter & English Fee Fight
- FTC Endorses Push For Broader Access To Biosimilar Drugs
- Pathology Trade Group 2nd To Sue FDA Over Lab-Test Rule
- The Regulatory Headwinds Facing Lab-Developed Tests
- 3 High Court Rulings May Shape Health Org. Litigation Tactics
- A New Way Forward For COVID Vaccine Lawsuit Immunity
- A Deep Dive Into Law360 Pulse's 2024 Women In Law Report
- These Firms Have The Most Women In Equity Partnerships
- The Big Issues A BigLaw Associates' Union Could Address
- J&J Boosting Cardio Portfolio With Up To $1.7B V-Wave Buy
- TPG Dumped Opioid Co. On 'Unsuspecting' Endo, Suit Says
- Biogen Paid To Help Curb Generic Tecfidera Sales, Says Suit
- NuVasive Beats Fraudulent Inducement Claim At Trial
- 9th Circ. Told Psilocybin Petition Is Backed By Precedent
- Jadex Sells Temperature-Controlled Packaging Biz For $137M
- Second Pharmacist To Avoid Meningitis Murder Trial
- Pennsylvania Litigation Highlights Of 2024: A Midyear Report
- It's Time For A BigLaw Associates' Union
- Israeli Co. Sues NC Packaging Firm For Severing $25M Deal
- Biotech Consultant Sues Ex-Partner To Force $2.5M Share Buy
- Fed. Circ. Quells Fears Over Double-Patenting Overreach
- Humana To Pay $90M To End 8-Year Medicare Drug FCA Battle
- Drexel Accounting Prof Convicted Of Evading Tax On $3.3M
- Baltimore Inks $152.5M Opioid Deal With Cardinal Health
- Birth Control Cos. Say Conn. Injury Suit Must Be Tossed
- How Justices Upended The Administrative Procedure Act
- States Get Teva Generic Price-Fix Case On Docket As 1st Trial
- Walgreens Didn't Disclose PFAS In Bandages, Shopper Says
- Parsing FY 2024 DOJ Criminal Healthcare Fraud Enforcement
- Apple Needs To Wait Its Turn In ITC, Masimo Tells Fed. Circ.
- Ex-CEO Wants Verdict In COVID Test Kit Fraud Case Tossed
- Avantor Sells Clinical Services Biz To PE Shop In $650M Deal
- Psilocybin Right-To-Try Petition To Get 9th Circ. Hearing
- Taxation With Representation: Cleary, Kirkland, Skadden
- NC Litigation Highlights Of 2024: A Midyear Report
- New Jersey Litigation Highlights Of 2024: A Midyear Report
- Talc Jury Delivers $63M Verdict Against J&J, Beauty Care Co.
- NIH Accused Of Wrongly Eliminating Cos. From $50B IT Deal
- Matthew Perry's Assistant And 2 Drs. Charged In Actor's Death
- LA Times Owner Sued Over Control Of Biotech Nonprofit
- Monsanto Gets 3rd Circ. Win In Roundup Failure-To-Warn Case
- Pharmacy Can't Dodge Novo Nordisk's Diabetes Drug Suit
- CMS Posts Final Costs For 1st Set Of Drugs After Negotiations
- Price-Fixing Claims Against Par Pharma Tossed After Ch. 11
- NC Small Biz Challenges VA Bid Process For Prostate Drug
- Pharma Co. TM Dispute Doesn't Belong In Florida, Judge Says
- Okla. Says 10th Circ. PBM Ruling Defies High Court Precedent
- Paul Hastings Adds M&A, Shareholder Activism Lawyer
- Costco Wants PFAS Kirkland Brand Baby Wipes Suit Tossed
- J&J Vision Unit Sues Ex-Marketing Exec Over Move To Rival
- NC Judge OKs $15.2M Deal For Medical Device Investors
- Grassley Asks HHS For Clarity On Cannabis Position
- Novartis' $45B Biz Can Survive If Generic Debuts, Judge Says
- AstraZeneca Freed From $107.5M Verdict In Pfizer Patent Case
- HHS Calls For More Research, Planning To Combat Heat Risks
- Samsung Biotech Unit Hit With Patent Suit Over Bone Drugs
- How Cos. With Chinese Suppliers Should Prep For Biotech Bill
- Calbiotech Beats Ex-Worker's 401(k) Retaliation Suit
- Suit Claims Giant Uses Banned, Toxic Oil In Orange Soda
- Zantac Judge Won't Step Aside Over Wife's Reed Smith Role
- Mirror, Mirror On The Wall, Is My Counterclaim Bound To Fall?
- Can Chapter 15 Bankruptcy Help Cannabis Businesses?
- SEC Drops Insider Trading Suit Against Ex-Mylan Exec
- Entresto Release Delayed As Novartis Goes To Fed. Circ.
- Mother Can't Revive Suit Against GE For Child's Brain Damage
- Spinal Implant Patents Verdict Must Stand, Pa. Judge Says
- NY, NJ And Conn. Score $4.5M Penalty Over Enzo Data Breach
- Janssen Wants New FCA Trial As Relators Seek $1.85B Win
- Fed. Circ. Restores J&J, Allergan's Viberzi IP After Del. Loss
- Former Sprinter Eyes Plea Deal In 2020 Olympics Doping Case
- DC Circ. Backs EPA's Ethylene Oxide Cancer Risk Value
- FTC Makes 2nd Request In Review Of Medical Device Co. Deal
- FTC's Drug Middlemen Probe Highlights Ongoing Scrutiny
- 'Clever' Scheme Is Concealing Talc Litigation Funding, J&J Says
- Ex-McCarter & English Client Wants To Undo Malpractice Loss
- Conn. Trial Attys Back McCarter's Bid For Punitive Award
- Playing Dungeons & Dragons Makes Me A Better Lawyer
- 3 Firms Drive $3.8B Carlyle-Baxter Kidney Care Deal
- Accused Accounting Prof Is No Tax Expert, NJ Jury Told
- States Want Teva Generic Price Fixing Case Tried 1st
- Glass Tempering Co. Loses Early Exit Bid In NC Patent Fight
- Paragard IUD Makers Gearing Up For Defect Dismissal Bid
- States Oppose Shkreli High Court Bid For $64M Disgorgement
- Del. Dispatch: Director Caremark Claims Need Extreme Facts
- Parsing NJ Court's Rationale For Denying Lipitor Class Cert.
- Pacira Patent On Surgery Pain Drug Voided In Win For Generic
- King & Spalding Adds Freshfields M&A Ace In Silicon Valley
- Del. Judge Says Vaccine IP Claim Actually Mandates Vaccine
- The Biggest Georgia Rulings Of 2024 So Far
- Catching Up With Delaware's Chancery Court
- 3 Firms Rep As Crown Buys Revance In $924M Deal
- Takeda Should Face Certified Antitrust Classes, Judge Says
- Delaware Jury Says Fecal Treatment Patents Are Worth $25M
- Valeant's Legal Gripe A Total 'Nothingburger,' Justices Told
- Medicare Drug Price Suit Nixed Over 'Forum Shopping' In Ohio
- Biotech Firms Mull Acquisition Offers Amid Shaky IPO Climate
- FDA Rejects Latest Effort To Treat PTSD With MDMA
- Biopharm Co. Alector Sued In Del. For Docs On Director Pay
- Novartis Wants DC Judge To Quickly Block Entresto Generic
- Pharmacy Escapes Recklessness Claim In Septic Shock Suit
- Vidal's Sanctions Make It Clear: Don't Mess With The PTAB
- Gilead Drug Ruling Creates Corporate Governance Dilemma
- Wash. AG Says Kroger Refusing To Delay Merger For Ruling
- 3 Leadership Practices For A More Supportive Firm Culture
- Merck To Buy Autoimmune Treatment Drug For Up To $1.3B
- UK Litigation Roundup: Here's What You Missed In London
- Mass. Atty, 2 Others Settle SEC Insider Trading Claims
- Pot Cos. Get Creative To Boost Brands Despite Feds' TM Ban
- Apple Wins Bid For 2 Trials In IP Dispute With Masimo
- Cancer Research Org. Is Right To Avoid Corporate Influence
- Cannabis Biz Real Estate Loan Considerations For Lenders
- Cooley Hit With Fla. Malpractice Suit Over Financial Docs
- Wilson Sonsini, A&O Shearman Guide $688M Biotech Merger
- Deals Rumor Mill: Roche, Thoma Bravo, Klarna
- Rising Star: Williams & Connolly's Elise Baumgarten
- E-Discovery Quarterly: Rulings On Hyperlinked Documents
- Exec Unlikely To Get New Trial In SEC's 'Shadow Trading' Suit
- Biotech Firm Can't Pause SEC Action During Appeal
- Abbott Brass Trim But Can't Nix Investors' Formula Recall Suit
- Judge's Pharma Comments Could Decide Ineligibility Appeal
- Advocates Tell 9th Circ. To Revive Invisalign Monopoly Suit
- Teva Finds Some Big-Pharma Friends In Inhaler Patent Fight
- NC Biz Court Bulletin: The Battles Making Summer Sizzle
- Amgen Waged Lawfare To Overcharge For Drug, Suit Claims
- Ex-Pharma Exec Gets 20 Months In SEC Contempt Case
- Loper Bright Limits Federal Agencies' Ability To Alter Course
- Law Firms Fight J&J Bid To Revive Talc Subpoenas
- 3 Firms Steer $405M G1-Pharmacosmos Pharma Deal
- 2 FDA Pros Join McGuireWoods From Reed Smith, DOJ
- Jury Deadlocks In Third Illinois Zantac Cancer Trial
- Rising Star: King & Spalding's Julia Zousmer
- Pennsylvania Legislation Passed In 2024: A Midyear Report
- AstraZeneca Can't Duck $107.5M Patent Loss To Pfizer Unit
- Baby Sock Co. Can't Beat Investor Suit, But SPAC Brass Can
- Fed. Circ. Told Edwards Filed Safe Harbor Suit With Bad Intent
- Tech Giants' Fight To Ax Fintiv Rule Returns To Fed. Circ.
- Denver Food Co. Fired VP For Younger Male, Suit Claims
- Life Sciences Credit Firm Symbiotic Launches With $600M
- FDA Posts Two Policy Memos On E-Cig Applications
- A Primer On EU's Updated Human Substance Regulations
- Pharma Co. Founder Beats Suit Over Short-Swing Trading
- Dem Lawmakers Back FTC's Kroger-Albertsons Challenge
- Ex-Pfizer Worker Who Traded On Paxlovid Secrets Gets 9 Mos.
- Penn Says BioNTech Owes Royalties For COVID-19 Vax
- Teaching Scuba Diving Makes Me A Better Lawyer
- Rising Star: White & Case's Adam Acosta
- The Road Ahead For Regulation Of Digital Twins In Healthcare
- Inari Agriculture Can't Sink Patent Case Over Corn Seed
- Indivior Accused Of Overstating Prospects Of 3 Opioid Drugs
- Chinese Drug Co. Says Sanctions In Valsartan MDL Too Harsh
- J&J, Generics Spar In Remand On Schizophrenia Drug Patent
- GSK Wins Second Ill. Trial On Zantac Cancer Claims
- Lawyers Can Take Action To Honor The Voting Rights Act
- Spectrum, Assertio Hit With Double-Derivative Suit In Del.
- Fla. Man Gets 44 Months For $5M MilliporeSigma Export Scam
- Centessa Beats Shareholder Suit Over Kidney Drug
- Catching Up With Delaware's Chancery Court
- CooperSurgical Says Lab Hid Flawed IVF Product Tests
- Freshfields, Wachtell Guide $925M CVC, Mallinckrodt Deal
- Rising Star: Ropes & Gray's Tara Fisher
- 3rd Circ. Ruling Shows Benefits Of IP Licenses In Bankruptcy
- Unclear Intellectual Property Laws Are Stifling US Innovation
- Health Tech Co. Beats Investor Data Platform Fraud Claim
- Ex-Exec Can't Escape Drug Co.'s Trade Secret Suit
- Wheeling & Appealing: The Latest Must-Know Appellate Action
- US Cannabis Policy Thwarts Research, Health Officials Say
- McKinsey's $78M Opioid Deal With Health Plans Gets OK
- Patients Ink $1M Deal To Settle Pharmacy Data-Breach Claims
- 3rd Circ. Backs Ex-NJ Firefighter's $50M Drug Fraud Sentence
- The Fed. Circ. In June: More Liability For Generic-Drug Makers
- PTAB Told To Punish Mylan For Allegedly Breaking Fintiv Vow
- Four Plaintiffs Tossed From Merck Gardasil Vaccine MDL
- UK Litigation Roundup: Here's What You Missed In London
- Male Sex Drug Labeled As 'Natural' Contains Viagra, Suit Says
- Calif. Jury Clears Bayer In Flea And Tick Med Antitrust Suit
- Latham, Ellenoff Rank Among Top Firms For July IPOs
- AliveCor Asks 9th Circ. To Revive Apple Watch Antitrust Case
- Chancery Denies Ex-InterMune CEO $6M Legal Fee Right
- JPML Won't Form MDL Of 35 Acne Product Benzene Suits
- Former Stimlabs Exec Doesn't Have To Hand Over Devices
- Novo Nordisk Loses Challenge To Medicare Drug Price Talks
- AbbVie Wants Mass. Biotech Firm To Pay Up For Drug Work
- MoFo Adds 3-Atty IP Litigation Team In NY From Desmarais
- Medtronic Still Faces Chancery Claim In Fortis' InPen Suit
- Expert Witness Standards Must Consider Peer Review Crisis
- R1 RCM Going Private In $8.9B Deal Steered By 4 Firms
- Analyzing Advance Notice Bylaws On 'Clear' Or 'Cloudy' Days
- DLA Piper Hires Longtime Williams & Jensen Partner In DC
- Biotech Co. Biedermann Motech Hits Ch. 11 With $34M Debt
- Hogan Lovells Recruits Two From Foley Hoag To Health Team